Tinea: Clinical Trials

38 trials for Tinea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 completed. 38 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 338Completed 38
Phase 23Completed 3

Follow Tinea: new trials by email Literature Review of Tinea trials Research Report on Tinea

Trials (filtered) newest first · largest first

All 38 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Essential Oils as Natural Therapies
application of cream "La Chinata" - Dermatophytoses, Skin Lesion
Phase 3CompletedUniversity of Extremadura492023-02-112023-12-15
A Therapeutic Equivalence Study of Ketoconazole Cream 2%
Experimental: Ketoconazole 2% Cream (Douglas Pharmaceuticals America Ltd.), Active comparator: Ketoconazole 2% Cream (Teva Pharmaceuticals USA), Placebo comparator: Placebo (Douglas Pharmaceuticals America Ltd.) - Tinea Pedis
Phase 3CompletedDouglas Pharmaceuticals America Ltd6822019-12-112020-08-06
Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
Candicort®, Nizoral®, Baycuten N® - Tinea
Phase 3CompletedAche Laboratorios Farmaceuticos S.A.1252019-06-112021-09-20
Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis
Ketoconazole Cream 2%, Ketoconazole Cream 2% (G&W Laboratories Inc.), Placebo - Tinea Pedis
Phase 3CompletedEncube Ethicals Pvt. Ltd.8312018-08-232019-06-27
Non-inferiority Trial of Dapaconazole Versus Ketoconazole
Dapaconazole, Ketoconazole - Tinea Pedis
Phase 3CompletedBiolab Sanus Farmaceutica3602017-11-012020-07-27
Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients
Efinaconazole Topical - Onychomycosis
Phase 3CompletedWestern University of Health Sciences402017-06-062020-10-30
Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis
Econazole Nitrate Cream, 1%, Placebo - Tinea Pedis
Phase 3CompletedMylan Inc.8762016-03-152022-03-07
Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis
P-3058 10%, vehicle of P-3058 10%, amorolfine 5% - Onychomycosis
Phase 3CompletedPolichem S.A.9532015-08-202018-09-26
Design and Clinical Evaluation of a School Meal With Deworming Properties
Ujiplus, Albendazole, uji - Helminthiasis, Tinea Capitis
Phase 2 / Phase 3CompletedKenya Medical Research Institute3262015-05-012016-09-07
BE Study of Naftifine HCL
Naftifine hydrochloride 2%, Placebo, Naftin® 2% (Naftifine hydrochloride 2%) - Tinea Pedis
Phase 3CompletedGenzum Life Sciences6932015-03-012017-05-11
Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population
P-3058 - Onychomycosis
Phase 3CompletedPolichem S.A.202014-08-012018-03-08
Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris
Naftin 1% Cream, Placebo Cream - Tinea Cruris, Jock Itch
Phase 3CompletedMerz North America, Inc.652013-08-012015-04-15
Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis
Luliconazole Solution, 10%, Vehicle Solution - Distal and Lateral Subungual Onychomycosis
Phase 2 / Phase 3CompletedTopica Pharmaceuticals3342012-05-012015-11-30
Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis
Terbinafine, Terbinafine Placebo - Tinea Pedis
Phase 3CompletedNovartis2902011-08-012013-12-27
Topical Antifungal Treatment for Tinea Pedis
33525, Placebo - Tinea Pedis
Phase 3CompletedMedicis Global Service Corporation3212011-07-012013-08-28
Topical Antifungal Treatment for Tinea Pedis
33525, Placebo - Tinea Pedis
Phase 3CompletedMedicis Global Service Corporation3222011-07-012013-08-28
Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis
Econazole Nitrate Foam 1%, Vehicle Foam, Econazole Nitrate Cream 1% - Tinea Pedis, Athlete's Foot
Phase 3CompletedAmDerma3362011-06-012012-09-28
Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
Product 33525 - Tinea Pedis, Tinea Cruris
Phase 3CompletedTinea Pharmaceuticals6042011-05-012013-01-23
Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis
Econazole Nitrate Foam 1%, Vehicle Foam - Tinea Pedis, Athlete's Foot
Phase 3CompletedAmDerma2642011-05-012013-01-09
Topical Antifungal Treatment for Tinea Cruris
33525, Placebo - Tinea Cruris
Phase 3CompletedMedicis Global Service Corporation4832011-05-012013-08-28

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Tinea Pedis (15)  ·  Onychomycosis (14)  ·  Foot Dermatoses (5)  ·  Mycoses (4)  ·  Tinea Capitis (4)  ·  Tinea Cruris (4)  ·  Keratoderma, Palmoplantar, Epidermolytic (2)  ·  Nails, Malformed (2)  ·  Onycholysis (2)  ·  Twenty-Nail Dystrophy (2)  ·  Yellow Nail Syndrome (2)  ·  Anemia (1)  ·  Cellulitis (1)  ·  Dermatomycoses (1)

Broader conditions

Bacterial Infections and Mycoses (38)  ·  Infections (38)  ·  Skin Diseases (38)  ·  Skin Diseases, Infectious (38)  ·  Skin and Connective Tissue Diseases (38)  ·  Dermatomycoses (37)  ·  Mycoses (34)  ·  Foot Diseases (20)  ·  Pathological Conditions, Signs and Symptoms (18)  ·  Foot Dermatoses (15)  ·  Pruritus (15)  ·  Signs and Symptoms (15)  ·  Skin Manifestations (15)  ·  Nail Diseases (14)

Interventions

Terbinafine (6)  ·  naftifine (4)  ·  Gels (2)  ·  Ketoconazole (2)  ·  Solutions (2)  ·  1-(2-(2,4-dichlorophenyl)-2-(4-(trifluoromethyl)benzyloxy)ethyl)-1H-imidazole (1)  ·  Albendazole (1)  ·  Calcium Dobesilate (1)  ·  Clotrimazole (1)  ·  Fluconazole (1)  ·  Griseofulvin (1)  ·  Itraconazole (1)  ·  amorolfine (1)  ·  betamethasone-17,21-dipropionate (1)  ·  dexamethasone acetate (1)

Sponsors

Merz North America, Inc. (5)  ·  Medicis Global Service Corporation (3)  ·  Novartis (3)  ·  Novartis Pharmaceuticals (3)  ·  Pfizer (3)  ·  AmDerma (2)  ·  Dow Pharmaceutical Sciences (2)  ·  Polichem S.A. (2)  ·  Ache Laboratorios Farmaceuticos S.A. (1)  ·  Bayer (1)  ·  Biolab Sanus Farmaceutica (1)  ·  Douglas Pharmaceuticals America Ltd (1)  ·  Encube Ethicals Pvt. Ltd. (1)  ·  Genzum Life Sciences (1)  ·  Kenya Medical Research Institute (1)

Countries

United States (26)  ·  Belize (6)  ·  Canada (6)  ·  Puerto Rico (6)  ·  Germany (5)  ·  Honduras (4)  ·  Dominican Republic (3)  ·  Iceland (3)  ·  Poland (3)  ·  Spain (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Czechia (2)  ·  El Salvador (2)  ·  France (2)

Top investigators

Lawrence Parish, MD (3)  ·  Ron Staugaard (3)  ·  Daniel Piacquadio, MD (2)  ·  Maurizio Caserini, MD (2)  ·  Bernard Goffe, MD (1)  ·  David M Harris, PhD (1)  ·  Elijah M Songok, PhD (1)  ·  Gilberto De Nucci, MD (1)  ·  Lalatendu Panigrahi (1)  ·  Lawrency Parrish, MD (1)

Results publications

PMID 25007364, PMID 21968664, PMID 22052309, PMID 23884486, PMID 30526582

NIH funding

2008 (1), 2015 (1)